Catalyst Wire Dossier Catalyst Wire Dossier

VIC-1911

· Vitrac Therapeutics, LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for VIC-1911, covering 2025-05-01 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of Lenvatinib Combined With VIC-1911 for the Treatment of Advanced HCC [NA]

See pricing